ApconiX Press Category archive
ApconiX Welcomes Lizzie Marriott ApconiX is delighted to welcome Lizzie (Elizabeth) Marriott in the Business Development team, who will work with existing and future customers to give them the nonclinical safety support they need in their drug development program. Academic Career Lizzie was born and grew up in Australia, [...]
In Conversation with Dr Emma Bishop We've been speaking with Dr Emma Bishop, a Senior Scientist in the immunotoxicology team at ApconiX. Emma updates us on her latest projects and research, as well as giving us some insight on her career development so far. So, I have it on [...]
ApconiX Welcomes Dr Rosie Alderson ApconiX is delighted to welcome Dr Rosie (Rosanna) Alderson as a content writer in the Marketing team. Rosie will be working with Dr Cynara Livera, Head of Marketing at ApconiX. Career Rosie left Lancashire to study her undergraduate degree in biochemistry at the University of Edinburgh. She really enjoyed the science and decided to pursue a PhD in Bioinformatics at the [...]
Improve Drug Project Success by Understanding Drug Target Safety Join Professor Ruth Roberts, Director and Co-founder, ApconiX Ltd, Dr Claire Sadler, Project Toxicologist, ApconiX and Dr Leigh Ann Burns Nass, President/Owner, Magnolia Toxicology Consulting, LLC in a live webinar on Thursday, October 1, 2020 at 11am EDT (4pm BST/UK) In [...]
Dr Guy Healing Appointed Honorary Professor ApconiX is pleased to announce that Dr Guy Healing has been appointed to an Honorary Professorship in the School of Pharmacy at the University of East Anglia (UEA), Norwich, UK. Guy first became involved with the UEA when he worked for AstraZeneca. One [...]
How Alderley Park Grew into an Innovation Hub A great piece in the Financial Times this week “How Alderley Park Grew into an Innovation Hub” which highlights the success of Alderley Park following AstraZeneca’s announced departure 5 years ago. Ned Wakeman talks about his team’s continued support of the start-up companies [...]
ApconiX Welcomes Ian Slater to the Team ApconiX is delighted to welcome Ian Slater to the team. Ian has spent many years in the pharmaceutical industry as a toxicology Study Director and Study Monitor and he joins our nonclinical study monitoring team. Ian was previously an Associate Principal Toxicologist [...]
Cost Effective Study Monitoring Services at Non-Clinical CROs in North America Steve Snyder is partnering with ApconiX to provide cost-effective study monitoring services at nonclinical CROs in North America. Steve is a US-based independent consultant who currently provides study monitoring services for clients ranging from global pharmaceutical companies to [...]
Study monitoring – What is it and why is it important to drug discovery projects? Guy Healing, Senior Toxicologist at ApconiX is interviewed by Jon Clements of Metamorphic PR Pharma companies need to ensure their drugs are safe but also that they work. In drug development, this requires numerous studies to [...]
ApconiX Welcomes Steve Snyder ApconiX is delighted to welcome Steve Snyder to the team. Steve joins the nonclinical study monitoring team and is based in Florida in the United States. Having worked at Wyeth, Eli Lilly, McNeil Pharmaceutical and Charles River, Steve has a wealth of experience in preclinical [...]
